Low-fat diets for acquired hypercholesterolaemia

被引:11
作者
Smart, N. A. [1 ]
Marshall, B. J. [2 ]
Daley, M. [3 ]
Boulos, E. [1 ]
Windus, J. [2 ]
Baker, N. [4 ]
Kwok, N. [1 ]
机构
[1] Bond Univ, Fac Hlth Sci & Med, Robina, Qld 4229, Australia
[2] Gold Coast Hosp, Nutr Dept, Queensland Hlth, Robina, Australia
[3] Queensland Hlth, Indigenous Hlth Serv, Palm Beach, Australia
[4] Queensland Hlth, Allied Hlth Directorate, Southport, Qld, Australia
来源
COCHRANE DATABASE OF SYSTEMATIC REVIEWS | 2011年 / 02期
关键词
CORONARY-HEART-DISEASE; LOW-DENSITY-LIPOPROTEIN; LIPID-LOWERING DIETS; LOW-CARBOHYDRATE; RISK-FACTORS; WEIGHT-LOSS; BLOOD-LIPIDS; BODY-WEIGHT; CARDIOVASCULAR-DISEASE; CHOLESTEROL LEVELS;
D O I
10.1002/14651858.CD007957.pub2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Hypercholesterolaemia, characterised by raised blood cholesterol levels, is not a disease itself but a metabolic derangement that often contributes to many diseases, notably cardiovascular disease. In most cases, elevated cholesterol levels are associated with high-fat diet, especially saturated fat, coupled with an inactive lifestyle. Less commonly, raised cholesterol may be related to an inherited disorder, familial hypercholesterolaemia. This systematic review is only concerned with acquired hypercholesterolaemia. Objectives To assess the effects of low-fat diets for acquired hypercholesterolaemia and to investigate the incidence of adverse effects from low-fat dietary interventions. We planned to compare the relative effectiveness of low-fat diets with calorie-restricted diets for acquired hypercholesterolaemia. We also wanted to look into the relative effectiveness of low-fat diets and pharmacological interventions for acquired hypercholesterolaemia. Search strategy Studies were obtained from computerised searches of The Cochrane Library, MEDLINE, EMBASE and databases of ongoing trials. Date of last search was February 2010. Selection criteria Otherwise healthy adults (equal to or greater than 18 years) with acquired (not familial) hypercholesterolaemia. We defined hypercholesterolaemia as either total cholesterol greater than 5.2 mmol/L, LDL-cholesterol greater than 3.0 mmol/L, HDL-cholesterol less than 1.0 mmol/L or a combination thereof, although investigators' definitions were also accepted. We wanted to include any low-fat dietary intervention, like low-fat and low-saturated fat diets, intended to lower serum total and LDL-cholesterol or to raise HDL-cholesterol. A low-fat diet was considered as a fat calorie intake less than 20% of the total calories. The minimum duration of the intervention had to be six months. We excluded studies in unhealthy people. Data collection and analysis Two authors were planned to independently assess risk of bias and extract data. Main results No study met our inclusion criteria. Authors' conclusions Well designed, adequately powered randomised controlled trials investigating patient-relevant outcomes of low-fat diets for otherwise healthy people with hypercholesterolaemia are required.
引用
收藏
页数:23
相关论文
共 95 条
[1]  
[Anonymous], ARCH INTERNAL MED
[2]  
[Anonymous], CURRENT PHARM DESIGN
[3]  
[Anonymous], HEALTH TECHNOL ASSES
[4]  
[Anonymous], TECHN REP SER WHO
[5]   Despite good compliance, very low fat diet alone does not achieve recommended cholesterol goals in outpatients with coronary heart disease [J].
Aquilani, R ;
Tramarin, R ;
Pedretti, RFE ;
Bertolotti, G ;
Sommaruga, M ;
Mariani, P ;
Ruffato, L ;
Catapano, M ;
Boschi, F ;
Dossena, M ;
Pastoris, O .
EUROPEAN HEART JOURNAL, 1999, 20 (14) :1020-1029
[6]   VARIATIONS IN LIPIDS AND PROTEINS OF LIPOPROTEINS BY FENOFIBRATE IN SOME HYPERLIPOPROTEINEMIC STATES [J].
AVOGARO, P ;
BON, GB ;
BELUSSI, F ;
PONTOGLIO, E ;
CAZZOLATO, G .
ATHEROSCLEROSIS, 1983, 47 (01) :95-100
[7]  
BAUMANN J, 1982, MED WELT, V33, P139
[8]  
Birley AJ, 1997, CLIN GENET, V51, P291
[9]   SYNERGISTIC EFFECT OF WEIGHT-LOSS AND CHANGES IN DIETARY LIPIDS ON THE SERUM-CHOLESTEROL OF OBESE MEN WITH HYPERCHOLESTEROLEMIA - IMPLICATIONS FOR PREVENTION OF CORONARY HEART-DISEASE [J].
BLACKET, RB ;
LEELARTHAEPIN, B ;
MCGILCHRIST, CA ;
PALMER, AJ ;
WOODHILL, JM .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1979, 9 (05) :521-529
[10]   The women's health trial feasibility study in minority populations: Design and baseline descriptions [J].
Bowen, D ;
Clifford, CK ;
Coates, R ;
Evans, M ;
Feng, ZD ;
Fouad, M ;
George, V ;
Gerace, T ;
Grizzle, JE ;
Hall, WD ;
Hearn, M ;
Henderson, M ;
Kestin, M ;
Kristal, A ;
Leary, ET ;
Lewis, CE ;
Oberman, A ;
Prentice, R ;
Raczynski, J ;
Toivola, B ;
Urban, N .
ANNALS OF EPIDEMIOLOGY, 1996, 6 (06) :507-519